Acambis reports earnings

Acambis (LSE:ACM; ACAM) reported a second quarter loss per share of 4.4p, down from EPS of 18.2p in the same period in 2004. Second quarter revenues were L6.4 million ($11.5 million), down 80% from L32.5 million in the second quarter of 2004. The company said the decline reflects lower revenues from its CDC contract for ACAM2000 smallpox vaccine, which is nearing completion. ...